Vis enkel innførsel

dc.contributor.authorGrønning, Kaja
dc.contributor.authorSharma, Archana
dc.contributor.authorMastroianni, Maria Adele
dc.contributor.authorKarlsson, Bo Daniel
dc.contributor.authorHusebye, Eystein Sverre
dc.contributor.authorLøvås, Kristian
dc.contributor.authorNermoen, Ingrid
dc.date.accessioned2021-04-20T10:22:58Z
dc.date.available2021-04-20T10:22:58Z
dc.date.created2020-11-16T14:02:49Z
dc.date.issued2020-03
dc.PublishedEndocrinology, Diabetes & Metabolism. 2020, 2020 (1), 1-5.en_US
dc.identifier.issn2398-9238
dc.identifier.urihttps://hdl.handle.net/11250/2738608
dc.description.abstractPrimary adrenal lymphoma (PAL) is a rare cause of adrenal insufficiency. More than 90% is of B-cell origin. The condition is bilateral in up to 75% of cases, with adrenal insufficiency in two of three patients. We report two cases of adrenal insufficiency presenting at the age of 70 and 79 years, respectively. Both patients had negative 21-hydroxylase antibodies with bilateral adrenal lesions on CT. Biopsy showed B-cell lymphoma. One of the patients experienced intermittent disease regression on replacement dosage of glucocorticoids. Learning points: Primary adrenal lymphoma (PAL) is a rare cause of adrenal insufficiency. Bilateral adrenal masses of unknown origin or in individuals with suspected extra-adrenal malignancy should be biopsied quickly when pheochromocytoma is excluded biochemically. Steroid treatment before biopsy may affect diagnosis. Adrenal insufficiency with negative 21-hydroxylase antibodies should be evaluated radiologically.en_US
dc.language.isoengen_US
dc.publisherBioscientificaen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titlePrimary adrenal lymphoma as a cause of adrenal insufficiency, a report of two casesen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright the authorsen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1530/EDM-19-0131
dc.identifier.cristin1848369
dc.source.journalEndocrinology, Diabetes & Metabolismen_US
dc.source.402020en_US
dc.source.141en_US
dc.source.pagenumber1-5en_US
dc.identifier.citationEndocrinology, Diabetes & Metabolism. 2020, 2020 (1), 19-0131.


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal